CryoCell International Inc (CCEL) - Total Liabilities
Based on the latest financial reports, CryoCell International Inc (CCEL) has total liabilities worth $78.00 Million USD as of August 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore CryoCell International Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
CryoCell International Inc - Total Liabilities Trend (1996–2024)
This chart illustrates how CryoCell International Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see CryoCell International Inc asset portfolio.
CryoCell International Inc Competitors by Total Liabilities
The table below lists competitors of CryoCell International Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Sungmoon Elect
KO:014910
|
Korea | ₩39.29 Billion |
|
Atico Mining Corporation
V:ATY
|
Canada | CA$65.45 Million |
|
Hudson Acquisition I Corp. Common Stock
NASDAQ:HUDA
|
USA | $7.47 Million |
|
Goodyear Indonesia Tbk
JK:GDYR
|
Indonesia | Rp846.81 Billion |
|
DIAMINES AND CHEMICALS ORD (BSE)
NSE:DIAMINESQ
|
India | Rs169.43 Million |
|
ATA Creativity Global
NASDAQ:AACG
|
USA | $403.71 Million |
|
ECM Libra Financial Group Bhd
KLSE:2143
|
Malaysia | RM78.99 Million |
|
Siab Holdings Bhd
KLSE:0241
|
Malaysia | RM547.51 Million |
Liability Composition Analysis (1996–2024)
This chart breaks down CryoCell International Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See CCEL equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.63 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -5.26 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 1.23 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CryoCell International Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CryoCell International Inc (1996–2024)
The table below shows the annual total liabilities of CryoCell International Inc from 1996 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-11-30 | $77.89 Million | +7.81% |
| 2023-11-30 | $72.25 Million | +8.79% |
| 2022-11-30 | $66.41 Million | +17.59% |
| 2021-11-30 | $56.48 Million | +15.58% |
| 2020-11-30 | $48.87 Million | -1.95% |
| 2019-11-30 | $49.84 Million | -2.84% |
| 2018-11-30 | $51.30 Million | +40.88% |
| 2017-11-30 | $36.41 Million | +4.18% |
| 2016-11-30 | $34.95 Million | +42.89% |
| 2015-11-30 | $24.46 Million | +16.84% |
| 2014-11-30 | $20.94 Million | +0.81% |
| 2013-11-30 | $20.77 Million | -2.62% |
| 2012-11-30 | $21.33 Million | -2.73% |
| 2011-11-30 | $21.93 Million | +11.23% |
| 2010-11-30 | $19.71 Million | -0.38% |
| 2009-11-30 | $19.79 Million | +10.24% |
| 2008-11-30 | $17.95 Million | -1.50% |
| 2007-11-30 | $18.22 Million | +8.92% |
| 2006-11-30 | $16.73 Million | +20.91% |
| 2005-11-30 | $13.84 Million | +10.92% |
| 2004-11-30 | $12.48 Million | +13.34% |
| 2003-11-30 | $11.01 Million | +175.50% |
| 2002-11-30 | $4.00 Million | +39.07% |
| 2001-11-30 | $2.87 Million | +79.37% |
| 2000-11-30 | $1.60 Million | +220.35% |
| 1999-11-30 | $500.00K | -72.22% |
| 1998-11-30 | $1.80 Million | +100.00% |
| 1997-11-30 | $900.00K | +80.00% |
| 1996-11-30 | $500.00K | -- |
About CryoCell International Inc
Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manu… Read more